H.R. 5745 · 117th Congress
COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
DunnSponsor2 cosponsors · 2 R
1 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
What it does: CRS summary · Introduced in House · Oct 27, 2021
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Latest action (Oct 28, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: Oct 27, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.